CANNAPHARMARX, INC. (CPMD) › Operating IncomeCANNAPHARMARX, INC. (CPMD) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2009: $113.7K2010: $585.6K2011: -$97.1K2012: -$89.6K2013: -$80.3K2014: -$3.97M2015: -$11.65M2016: -$1.00M2017: -$6.6K2018: -$954.3K2019: -$15.98M2020: -$14.49M2021: -$2.99M2022: -$5.21M2023: -$1.58M2024: -$3.63M2025: -$3.35M-$3.35M2009Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$3.35M+7.8%2024-$3.63M-129.6%2023-$1.58M+69.7%2022-$5.21M-74.1%2021-$2.99M+79.3%2020-$14.49M+9.3%2019-$15.98M-1574.3%2018-$954.3K-14287.4%2017-$6.6K+99.3%2016-$1.00M+91.4%2015-$11.65M-193.2%2014-$3.97M-4848.9%2013-$80.3K+10.3%2012-$89.6K+7.8%2011-$97.1K-116.6%2010$585.6K+414.9%2009$113.7K—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share